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Overview of Inhalation Toxicology
by Michael A. Dorato*
The development of inhalation toxicology as a distinct discipline can be traced back well over one
hundred years. The technology has advanced in terms of materials and designs used to construct
inhalationchambersandtheequipmentusedtogeneratecontrolledtestatmospheresofawidevariety
of gases, vapors, dusts, and droplets. Consideration of metered dose inhalers, a relatively recent
concern, has led to the design of new equipment for administering this unique dosage form. The
parameters used to evaluate inhalation toxicity are similar to those used for any other route of
administration. In addition, there are some unique procedures for early screening ofpulmonary tox-
icity, especially within a series of related chemicals.
Introduction
Thedevelopmentofinhalationtoxicology as adistinct
discipline canbetracedbackwell over acentury. Fraser
etal. (1)provided abriefreview ofthisearlyperiod and
adescription ofinhalationtechnology upto 1959. Inhala-
tiontoxicologytechnology hasexperienced continuous
development inthe types ofmaterials anddesigns used
inconstructinginhalation chambers. Excellent reviews
ofinhalation technology have been provided by Camp-
bell (2), Phalen (3), Drew (4), and MacFarland (5).
The following article will present an overview of
aspectsofcurrenttechnologyapplied toinhalation tox-
icologystudies, withoutattemptingtoreviewtheentire
spectrumofthesestudies. Someemphasiswillbeplaced
on studies with metered dose inhaler (MDI) aerosols,
either for intranasal or pulmonary administration, as
these represent an area of interest in drug delivery
system development. Studydesign and inhalation toxi-
city assessment will be briefly considered.
Inhalation Toxicology Technology
Five basic types ofinhalationtoxicology studies have
been described: whole body, head only, nose only, lung
only, andpartiallung(6). Each exposuretypehasits own
unique set of advantages and disadvantages.
The advantages of whole-body inhalation systems
include the ability to expose large numbers of animals
sinultaneously, accommodate awidevarietyofspecies,
employminimalrestraint, andsuitabilityforchronicin-
halation exposures. Themajordisadvantagesincludethe
large quantity of test material required for conduct of
studies, multiple routes of exposure, distribution of
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concentration and particle size within the chamber ex-
posurezone, controlofchamberenvironment, andcost.
Head only and nose only inhalation exposure sys-
tems aresimilarenoughtoshareadvantagesanddisad-
vantages. The advantagesinclude relative efficiency in
usageoftestmaterial, reductionoreliminationofmulti-
ple exposure routes, and containment of highly toxic
materials. Themajordisadvantages arethe laborinten-
sive nature of head/nose only exposure systems, ade-
quate exposure seals about the face or neck of animal
models, and stressrelatedtothe restraintnecessaryfor
head/nose-only exposure studies.
Stresshas, untilrecently, beenamajorlimitingfactor
indeterminingthedurationofhead/noseonlyexposure
studies(4).Theneedtorestrainanimalsintubeshasbeen
assumedtoproduceanundesirablelevelofstresswhen
prolonged exposure is required. Smith et al. (7) have
reportedthatlong-term noseonlyexposures, up to 7 hr
perday, werepossiblewithlittleornostress. Parameters
such as body weight, rectal temperature, clinical path-
ology, andplasmacorticosterone levelswereusedtoin-
dicatethelackofmeasurablestressinratsandhamsters
forprolonged exposure periods. Laperand Burgess (8),
however, havereportedanincreaseintheacuteinhala-
tion toxicity related to restraint-induced stress.
Lung only and partial lung exposure techniques are
also similar enough to share advantages and disadvan-
tages. The major advantages are limited routes of
exposure, directknowledgeoftheactualquantityoftest
material delivered to the lung, and uniform delivery of
multiple doses. Using other modes of inhalation ex-
posure, i.e., wholebody, thedosereceivedduringanin-
halation exposure is a complex relationship between
physiologic(rate, depth, andvolume), andphysical(par-
ticle size, collection efficiency, and retention) parame-
ters. Disadvantagesofthelimitedlungexposuretechni-
ques include the need for anesthesia and physiologicM. A. DORATO
support, bypassingthenose, technicaldifficulty, limited
numberofanimals that can be studied atany one time,
and distribution of dose within the lung. Instillation of
solutions or suspensions results in heavy, centralized
depositsofmaterial. Inhalationresultsinalighter, even
and widely distributed dose (9). While lungonly orpar-
tial lung dosing procedures do not lend themselves to
largescale screening/testing programs, theydohaveap-
plicationinstudiesofabsorption, metabolism, distribu-
tion, and excretion.
The design and construction of inhalation chambers
have been extensively reviewed (3-5,10,11). Glass and
various plastics have been used to construct inhalation
chambers. Plastics, in general, tend to age rapidly with
use. Both glass and plastic can build areas of high
static charge, an undesirable feature in inhalation
studies. Stainless steel is a common, and satisfactory
material to use in inhalation chamber construction
(Fig. 1). Glass windows are provided for observation.
The poor thermal insulation properties of steel can be
integrated intoachamberenvironmentalcontrolsystem
(discussed later).
Inhalation exposure systems can be either static (no
airflow) ordynamic(airflow). Staticinhalationexposure
systems, whereadefinedquantityoftestmaterialisin-
troduced into a closed system and allowed to mix with
the trapped air, are efficient in terms of test chemical
usage. Static exposure systemsare limited bydepletion
ofoxygen, accumulation ofwaste, andlossoftestagent.
They are generally unsuitable for most inhalation tox-
icology studies under current standards. Most modern
inhalation exposure systems are of the dynamic type
(Fig. 2). Dynamicexposure systemsarecharacterizedby
a continuous replacement of chamber air and test
material.
The concentration profile in a dynamic inhalation
system rises rapidly, then asymptotically approaches a
theoreticalequilibrium value(Fig. 3). Thisphenomenon
wasreportedbySilver(12), whoalsodescribedthetime
necessary to reach a desired percent ofthe theoretical
equilibrium concentration:
chamber volume = 4.605 chamber airflow
t = time to 99% of theoretical
equilibrium concentration.
Referring to Figure 3, the exposure duration for a
dynamic system isgenerallyconsidered tobethe inter-
valbetweenstarting(ta)andstopping(tb)thegeneration
system. The animals, however, remain in the exposure
systemforatimeequivalenttotheinitialtw (tc-tb).The
suggestion by the National Ibxicology Program (NTP)
that exposure duration should be defined as the inter-
val tc-ta has not met with universal acceptance (4).
Theperformanceofinhalationexposuresystems -i.e.,
leakage, material loss, and uniformity of concen-
tration - has been addressed (13,14) and wrln not be
reviewed here.
lTble 1. Inhalation chamber environmental factors.a
Parameter Effect
lemperature Activity, ventilation
Relative humidity Particle size, respiratory tract
environment, ventilation
Atmospheric pressure Ventilation cardiac function,
respiratory tract environment
Airflow Distribution, equilibration,
contaminants
Air quality Ventilation, stress
Noise/vibration Stress
aFrom Phalen (3).
A requirement for currently performed inhalation
studies is the ability to provide a consistently clean air
supply, sourced from ambient air, to chambershousing
control and treated groups. Environmental control,
therefore, isanimportantaspectofinhalationexposure
system design.
Unusualenvironmentalconditionsmayplaceanaddi-
tional, and unwanted stress ontestanimals. Theability
to produce, control, and monitor the required envi-
ronment should be abasic consideration in conducting
inhalation studies. Environmental fact ors such as
temperature, relative humidity, atmospheric pressure,
airflow, airquality, noise, andvibrationcouldaffectthe
evaluation of toxicity (Table 1). Physical activity,
respiratory patterns, and respiratory tract mucus may
beaffectedbytemperature andhumidity. Notonlyisit
important to have a well-controlled environment for a
particularinhalationchamber, butallchambersusedin
a study should be controlled within the same limits.
Variations in the inhalation chamber environment
may affect experimental animals and exposure atmo-
spheres (15,16).
One environmental parameterthat has received par-
ticularattentionistemperature. Tbmperaturecouldhave
animportant effect onsurvivaloftestanimals. In ady-
namicinhalationsystem, heatproducedbytestanimals
is transferred to chamber walls and then to exposure
roomsbyradiation, particularlyinthecaseofsteelwalls.
Heat from animals is transferred to the chamber airby
convection (16).
Figure4presentsaschematicoftheinhalationcham-
bercontrol system used at Lilly Research Laboratories.
Thesystemwasdesignedtoprovideverycleanair. Italso
controls, monitors, andreportsthechamber'stempera-
ture, dewpoint, airflow and differential pressure, and
roomtemperature. Recognizingthatsteelchamberwalls
providelittlethermalinsulation, theeffectonchamber
temperaturerelatedtothedifferentialbetweenchamber
and room temperature was integrated into the control
design. The system was designed to provide an initial
roomtemperature2°Cbelowthechambertemperature
set point. The system then adjusts room temperature
so thatchamberinletductheatersoperateat20to80%
of capacity. Each parameter is controlled within user-
defined limits and is accessible through a personal
computer.
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FIGURE 1. A series of 9 m3 stainless steel and glass inhalation FIGURE 3. Concentration profile of a dynamic inhalation exposure
chambers (Lilly Research Laboratories). system.
Exhaust
FIGURE 2. Dynamic inhalation exposure system.
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FIGURE 4. Schematic of environmental control system for inhalation exposure chambers. I/P, current to pressure; HE, HT, HI, dew point
element, transmitter, and indicator, respectively; TE, Ti, TI, temperature element, transmitter, and indicator, respectively; DP, DPI,
differential pressure and differential pressure indicator; V, conversion of differential pressure to flow.
Table 2. The range of individual chamber conditions
over a 90-day operation period.
Inhalation Differential
chamber Airflow, pressure, Temperature, Dew point,
number L/mina cm H2Ob occ oCd
1 High 2007 2.03 21.0 11.3
Low 1991 1.96 20.9 10.8
2 High 2005 2.02 21.0 11.4
Low 1991 1.98 20.9 10.8
3 High 2008 2.02 21.0 11.4
Low 1991 1.96 20.9 10.8
4 High 2006 2.03 21.0 11.1
Low 1993 1.97 20.9 10.8
aSet point = 2000 L/min.
bSet point = 2.0 cm H20.
cSet point = 210C.
dSet point = 11°C.
Thesystemalsoallowsforadequatecontrolofmultiple
inhalation chamber environments (Thble 2). Additional
attention isgiven to chamber exhaust so that it is prop-
erly cleaned by baghouse and HEPA filters and vapor
scrubbing systems.
As previously mentioned, whole body inhalation ex-
posure systemshavethedisadvantage ofmultiple routes
of exposure, i.e., dermal, ocular, oral, and inhalation.
Griffis et al. (1?) estimated 60 to 80% of dermally
depositedmaterialcouldreachthegastrointestinal tracts
of some test animals.
Nose only exposure systems were designed to reduce
oreliminate multiple routesofexposure(Figure5). Most
noseonlysystems, however, havenotaddressedtheissue
of providing fresh air and aerosol to animals in a verti-
cletierarrangement(Figure6A). Toaddressthis, amulti-
levelflow-pastchamberdesign(Figure6B) wasreported
by Cannon et al. (18). The system apparently addresses
the problems of large material requirements, surface
losses, andaerosoldepletionbytestanimals as one moves
from the top tier to the bottom tier. In contrast to the
conventional nose only exposure systems, each animal
is supplied with fresh aerosol (Figure 6A and B).
As with whole body exposure systems, temperature
is a critical parameter in nose only designs. Typically,
each animal is restrained in glass, plastic, or steel
restrainingtubes(Figure6). Since ratsandmiceregulate
bodytemperaturethroughtheirtails, asimpleapproach
would be to allow their tails to protrude from the
restrainttubesintoacoolerambientenvironment. Rats
have been monitored for up to 8 hr in tail-out restraint
tubeswithnochangeinbodytemperature. Anadditional
advantage ofrestrainingtubes is the ability to monitor
respiratory parameters during aerosol exposure (19).
Noseonlyornose/mouthexposuresystemsarealsoap-
plicable to studies with large animals. A typical system
is designed around face masks (Figure 7). Poynter and
Spurling (20) described a system for administration of
metered dose inhalation(MDI) aerosols to test animals.
Theirsystemwasmodifiedtoincorporate aflexibleoro-
pharyngeal tube and opposing one-way valves to limit
rebreathingfromtheaerosolchamber(Figure8). Inspira-
tionandexpirationaremonitored, andMDIaerosolsare
shaken and delivered accordingto apredetermined se-
quence of breaths, only during inspiration.
Thecompletevarietyofaerosolgenerationtechniques
is beyond the scope of this overview.
Study Design
Thedesignofinhalationtoxicologystudiesshouldcon-
sidertheneedtoevaluatebothlocalandsystemiceffects
of the test material and the formulation components.
Acuteinhalationtoxicology studiesare conducted with
a single exposure of usually 1 to 4 hr (Thble 3). The rat
is the usual species for conducting acute inhalation
studies, usingeitherwhole body or nose only exposure
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FIGURE 5. Nose-only exposure systems for rodents (Courtesy of
BioResearch Laboratories, Quebec, Canada.)
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FIGURE 7. Mask-type exposure system for lavage animals. (Courtesy
of BioResearch Laboratories, Quebec, Canada.)
A
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B
FIGURE 6. Diagram of nose-only inhalation exposure systems. (A)
Conventional system; (B) flow-past system. Modified from
Cannon et al. (18).
FIGURE 8. Metered dose inhaler dosing system (Lilly Research
Laboratories).M. A. DORATO
Table 3. Acute inhalation toxicology study design.
Five animals/sex, two species
Up to five exposure levels
Whole body or nose/head only
Single 1- to 4-hr exposure
14-Day observation period
Necropsy (histopathology recommended)
systems. A 14-dayobservationperiodandagrossnecrop-
sy follow the single exposure. Histopathology is recom-
mended but notrequired. The purpose ofacute inhala-
tion exposure studies isto establish an index ofrelative
toxicity, i.e., lethality, andjustify exposure concentra-
tions for longer term studies.
Acutemultidoseinhalationstudies(Thble4)aresimilar
in design. Multiple exposures of 1 to4 hrare conducted
over a 14-day period, using either whole body or nose
onlyexposuresystems. Althoughcontrolgroupsarenot
usuallydesignedintosingleexposure acutestudies, they
are recommended formultiexposure studies. After the
lastexposure, anecropsyandhistologicalevaluations are
usuallyperformed. Theprimarypurposeistochooseex-
posure levels for subchronic studies.
Subchronic inhalation studies(Thble5)are conducted
over a 30- to 180-day period. Exposure durations are
usually 1 to 6hrperday, 5to 7 daysperweek. A control
groupandthreetofiveexposuregroupsareusually used.
Interim clinical evaluations, i.e., hematology, clinical
chemistry, andurinalysismaybeincluded. Theexposure
period is followed by a complete necropsy and histo-
pathology. The primary purpose is tojustify exposure
concentrations for chronic studies. The data from all
studies up to this point would be suitable for inclusion
in investigational new drug applications or for setting
preliminary worker exposure guidelines.
Chronic/oncogenicstudies(Thble6)areconductedover
thelifetimeofthetestspecies, usuallyratsandmice. The
exposure durationmaybeupto23hrperday, 5to7days
perweek, for52 to 104weeks. Acompletenecropsyand
histopathology isperformedafterthelastexposure. The
purpose is to determine the toxicity due to extended
repeat exposures, a no-observable effect level, and on-
Table 4. Acute multiexposure inhalation toxicology design.
Five to ten animals/sex, two species
Control group plus up to five exposure concentrations
Whole body or nose/head-only
1-4 hr daily for 14 days
Daily observation
Necropsy/histopathology
lTble 5. Subchronic inhalation toxicology study design.
10-20 animals/sex, two species
Control group plus three to five exposure concentrations
Whole body or nose/head-only
1-4 hr/day, 5-7 days/week from 90-180 days
Interim clinical evaluation
Necropsy/histopathology
Table 6. Subchronic inhalation toxicology study design.
10-30 animals/sex, plus satellite group, two species
Control plus at least three exposure groups
Whole body or nose/head-only
1-23 hr/day, 5-7 days/week, 52-104 weeks
Interim clinical evaluation
Necropsy/histopathology
cogenic potential. Gross (21) has prepared a review of
regulatory guidelines and recommendations.
Theintranasalrouteiscommonlyusedforpeptideand
protein drugs. Its advantages are: no metabolism in the
gut wall, no destruction by gastrointestinal fluids, and
avoidance of extensive first-pass hepatic metabolism.
Theintranasalroutealsoprovidesanalternatetointra-
muscularadministration. The exposure technologydif-
ferssomewhatfromconventionalinhalationstudies, but
the study designs are similar. For all inhalation studies,
gross examination ofthe nasalcavity at necropsy limits
the usefulness ofhistopathologic examination. It is not
recommendedforstudiesspecificallydesignedtodeter-
mine effects on nasal mucosa (22).
Assessment of Toxicity
The assessment of toxicity in inhalation studies is
similartothatused fortoxicology studiesconductedby
anyotherrouteofadministration. Arangeofdoses/con-
centrations is studied; dose/concentration-related ef-
fectsareevaluated, usuallyforbothsexes, inoneormore
species.
Common protocols include the assessment of: body
weight, foodconsumption, clinicalsignsoftoxicity, clini-
calpathology(hematology, clinicalchemistry, urinalysis),
ophthalmology, grossnecropsy(exceptnasalcavity), and
histopathology. Thepurposeistodeterninetheinherent
toxicity of specific agents. In doing so, one must make
a distinction between toxicity and hazard (21). While
manyproceduresareapplicabletotheassessmentofin-
halation toxicity, three that have been found useful in
screeningpotentialintranasalandpulmonarydrugswill
be briefly reviewed here.
Hussein et al. (23) described a method for studying
nasalabsorption and irritation in rats. Briefly, anesthe-
tizedratsaresurgicallypreparedtoallowretrogradeper-
fusion of the nasal cavity while they are breathing
through atrachealcannula. Thisprocedure wasusedto
evaluate the bioavailability and nasal irritation of
clofiliumtosylate(24). Nasaladministration ofthisdrug
appearedtobesuperiortooraladministration, interms
of bioavailability. Dose-related nasal epithelial cell
necrosisandsloughingwerealsoreported. Eventhough
surgical preparation was required, this procedure has
provenusefulinthescreeningofactiveingredients, for-
mulationacids, andcompleteformulationsintendedfor
intranasal administration.
Bronchoalveolarlavagefromanimalsacutelyexposed
tovarioustestmaterials, eitherbyinhalationorinstilla-
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¶Nble 7. Nasal cavity lavage (Swiss mice).
Test LDHa Proteinb
SLSC 181 223
TX-lOOd 519 414
S85e NR NR
SCGI NR NR
aPercent of deionized water control: 16.7 + 4.08 IU/L.
bPercent of deionized water control: 67.3 ± 29.94 ti/L.
cSLS, sodium lauryl sulfate.
dTX-100 = Triton X-100.
eS85= Span 85.
fSCG = sodium chromoglycate.
tion, has been applied as a rapid screen for lunginjury
(25,26). The various lavage parameters that could be
evaluated and their significance have been reviewed
(27). In particular, total lactate dehydrogenase and its
isoenzymepatterncanbeusedtodetectrespiratorytract
toxicity. Beck et al. (28) suggested that lactate dehy-
drogenase levels in lunglavage fluid may not be appro-
priate for evaluating upper airway effects.
We have found that lavage of the upper respiratory
tract, similar to the procedure described by Hussein et
al. (23), didprovide ameasureofupperrespiratorytract
effectsforsodiumlaurylsulfateandTritonX-100. Span
85andsodiumchromoglycatedidnotproduceadetect-
able response (Thble 7). The usefulness of lavage fluid
analysis is greatest as a comparative measurement of
structurally and toxicologically related materials and
somewhat less useful when comparing agents that act
through different mechanisms (28).
Alarie(29)haswrittenextensively onthesensoryirri-
tationtechnique. Briefly, miceareplacedinaplethysmo-
graphandexposedtoincreasingairborneconcentrations
80
control ( exposure
t | |~~~~1 0.031 limole/L
o 0.111 pinole/AL
E 60-*-- O.lll ±mole/L
0.492,umole/L
320
- t
of various agents. A concentration-related decrease in
respiratory rateisfoundforthose agentsthatstimulate
thistrigeminalreflex. Similartotheresultsofthelavage
studymentionedabove, sodiumlaurylsulfate(Figure9)
and Triton X-100 were judged to be sensory irritants,
while Span 85 and sodium chromoglycate were not.
When faced with the evaluation of many chemicals
within a particular structure-activity relationship, the
abovemethodsrapidlyprovidecomparativeinformation
in the form of acute and subacute responses.
Conclusion
Inhalation studieshavebeenconducted forwell over
100years. Whilethebasicprinciplesmayhave changed
little, inhalation technology has been in a state of con-
tinuous evolution. The need to develop techniques for
testingawidevarietyofgases, vapors, particulates, and-
dropletshasledtothedevelopmentofuniquegenerating
systemsandtheuseofavarietyofmaterialsanddesigns
for construction ofinhalation chambers. Dose/concen-
trationresponserelationshipsareusuallyevaluatedus-
ingparameterscommontomosttoxicologystudies. Other
proceduressuchasinstillation, lavage, andairwayirrita-
tion are useful for the rapid screening of agents for
respiratory tract injury, especially when attempting to
discriminate betweenrelatedmembersofaclassofdrugs
under development.
The author wishes to thank the staffof the inhalation toxicology
laboratory, K. Carlson, T. Markey, B. Hughes, D. Herman, R. Potter,
R. Tielking, and M. Collins; and R. Frost-Bessand S. Zeilingafortyp-
ing this manuscript.
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FIGURE 9. Sensory irritation response of sodium lauryl sulfate.
169170 M. A. DORATO
REFERENCES
1. Fraser, D. A., Bales, R. E., Lippman, M., and Stokinger, H. E.
Exposure chambers for research in animal inhalation. US Pub-
lic Health Service, Publ. No. 50, USGovernment PrintingOffice,
Washington, DC, 1959.
2. Campbell, K. I. Inhalation toxicology. Clin. Ibxicol. 9(6): 849-921
(1976).
3. Phalen, R. F. Inhalation Studies: Foundations and Techniques.
CRC Press, Boca Raton, FL, 1984.
4. Drew, R. T. The design and operation of systems for inhalation
exposure of animals. In: Ibxicology of Inhaled Materials (H. P.
Witschi and J. Brain, Ed.), Springer Verlag, New York, 1985.
5. MacFarland, H. N. Designs andoperational characteristics ofin-
halationexposureequipment-areview. Fundam. Appl.Toxicol.
3: 603-613 (1983).
6. Phalen, R. F. Inhalation exposure of animals. Environ. Health
Perspect. 16: 19-24 (1976).
7. Smith, D. M., Ortiz, L. W., Archuleta, R. F., Spaulding, J. F., Tillery,
M. I., Ettinger, H. J., and Thomas, R. G. A method for chronic
nose-only exposures of laboratory animals to inhaled fibrous
aerosols. In: Inhalation Ibxicology and Iochnology(B. K. J. Leong,
Ed.), Ann Arbor Science, Ann Arbor, MI, 1980.
8. Laper, C. A., and Burgess, B. A. The effects of restraint in the
acutetoxicityofcarbonmonoxide. Tbxicologist 1: 138-139(1981).
9. Brain, J. D., Knudson, D. E., Sorokin, S. P., and Davis, M. A.
Pulmonary distribution of particles given by intratracheal
installation orbyaerosoladministration. Environ. Res. 11: 13-35
(1976).
10. Hinners, R. G., Burkhart, J. K., and Punte, C. L. Animal inhala-
tion exposure chambers. Arch. Environ. Health 16: 194-200
(1968).
11. Jensk, J. V., and Phillips, G. B. Aerosol challenge ofanimals. In:
Methods of Animals Experimentation, Vol. 1 (W. Gay, Ed.),
Academic Press, New York, 1965, pp. 274-341.
12. Silver, S. D. Constant flow gassing chambers: Principles influ-
encing design and operation. J. Lab. Clin. Med. 31: 1153-1161
(1946).
13. Hemenway, D. R., Carpenter, R. L., and Moss, D. R. Inhalation
toxicologychamberperfonnance: aquantitative model. Am. Ind.
Hyg. Assoc. J. 43: 120-127 (1982).
14. Moss, 0. R. Comparison of three methods of evaluating inhala-
tiontoxicology chamber performance. In: Inhalation loxicology
and Technology (B. K. L. Leong, Ed.), Ann Arbor Science, Ann
Arbor, MI, 1981, pp. 19-28.
15. Hinners, R. G. A system for automatically monitoring chamber
temperature, humidity, and pollutant concentration. In: Work-
shop on Inhalation Chamber Technology (R. T. Drew, Ed.), Na-
tional Technical Information Service, VA, 1978, pp. 89-94.
16. Bernstein, D. M., andDrew, R.T.Themajorparametersaffecting
temperature inside inhalation chambers. Am. Ind. Hyg. Assoc.
J. 41: 420-426 (1980).
17. Griffis, L. C., Wolff, R. E., Beethe, R. L., Hobbs, C. H., and
McClellan, R. 0. Pulmonary deposition of a 99lET labeled aero-
solinawhole-bodyexposure. In: Inhalation 1bxicology Research
Institute Annual Report. Lovelace Biomedical Environmental
Research Institute, Albuquerque, NM, 1979, pp. 259-266.
18. Cannon, W. C., Blanton, E. F., and McDonald, K. E. The flow-
past chamber: an improved nose-only exposure system for
rodents. Am. Ind. Hyg. Assoc. J. 44(12): 923-928 (1983).
19. Dorato, M. A., Carlson, K. C., and Copple, D. L. Pulmonary
mechanics in conscious Fischer 344 rats. Toxicol. Appl. Pharm-
acol. 68: 344-353 (1983).
20. Poynter, D., and Spurling, N. W. Some cardiac effects of beta-
adrenergic stimi'lants in animals. Postgrad. Med. J. 47: 21-25
(1971).
21. Gross, S. B. Regulatory guidelinesforinhalationtoxicitytesting.
In: Inhalation lbxicologyandTechnology (B.K.J. Leong, Ed.), Ann
Arbor Science, Ann Arbor, MI, 1981, pp. 270-298.
22. Young, J. T. Histopathologic examination ofthe rat nasal cavity.
Fundam. Appl. Tbxicol. 1: 309-312 (1981).
23. Hussein, A., Hirai, S., andBawarshi, R. Nasal absorption ofpro-
pranololfromdifferentdosagesformsbyratsanddogs. J. Pharm.
Sci. 69(12): 1411-1413 (1980).
24. Su, K. S. E., Campanale, K. M., andGries, C. L. Nasaldrugdelivery
systemofaquaternaryammoniumcompound: clofiliumtosylate.
J. Pharm. Sci. 75(9): 1251-1254 (1984).
25. Mauderly, J. L. Bronchopulmonary lavage of small laboratory
animals. Lab Animal Sci. 27: 255-261 (1977).
26. Henderson, R. F., Damon, E. G., and Henderson, T. R. Early
damage indicators in the lung. I. Lactate dehydrogenase activ-
ity intheairways. Tbxicol. Appl. Pharmacol. 44: 291-297(1978).
27. Henderson, R. F. Use of bronchoalveolar lavage to detect lung
damage. Environ. Health Perspect. 56: 115-129 (1984).
28. Beck, B. D., Gerson, B., Feldman, H. A., andBrain, J. D. Lactate
dehydrogenase iso enzymes in hamster lung lavage fluid after
lung injury. 'Ibxicol. Appl. Pharmacol. 71: 59-71 (1983).
29. Alarie, Y Sensory irritation of the upper airways by airborne
chemicals. Ibxicol. Appl. Pharmacol. 24: 279-297 (1973).